Table 2 IMP3 signatures in cases and controls and IMP3 overexpression in serous tubal intraepithelial carcinoma and pelvic serous carcinoma
From: IMP3 signatures of fallopian tube: a risk for pelvic serous cancers
Group | #case | Mean | IMP3 signatures | STIC | PSC |
|---|---|---|---|---|---|
|  |  | age | (Total#) | #of + cases/HR (%) | #of + cases (%) |
LR | 196 | 48.6 | 25 | 0 (0) | 0 (0) |
HR | 60 | 46.2 | 226 | 5/9 (55) | 0 (0) |
PSC | 60 | 61.5 | 184 | 11/19 (58) | 38 (63) |